Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
Fatty acid synthase (FASN) expression is elevated in several cancers, and this over-expression is associated with poor prognosis. Inhibitors of FASN, such as orlistat, reportedly show antitumor effects against cancers that over-express FASN, making FASN a promising therapeutic target. However, large...
Guardado en:
Autores principales: | Yukie Yoshii, Takako Furukawa, Nobuyuki Oyama, Yoko Hasegawa, Yasushi Kiyono, Ryuichi Nishii, Atsuo Waki, Atsushi B Tsuji, Chizuru Sogawa, Hidekatsu Wakizaka, Toshimitsu Fukumura, Hiroshi Yoshii, Yasuhisa Fujibayashi, Jason S Lewis, Tsuneo Saga |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f05c698d43041ccb4452ef9e7cbc8d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan
por: Lieke Joosten, et al.
Publicado: (2017) -
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes
por: Alessandro Ruggiero, et al.
Publicado: (2010) -
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
por: Rangger C, et al.
Publicado: (2012) -
Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenografts
por: Christensen E, et al.
Publicado: (2018) -
Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer
por: Rainone P, et al.
Publicado: (2017)